Geode Capital Management, LLC Veracyte, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,844,713 shares of VCYT stock, worth $72.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,844,713

Previous 1,826,792 0.98%

Holding current value

$72.1 Million

Previous $39.6 Million 58.58%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$21.0 - $35.25 $376,341 - $631,715	17,921 Added 0.98%	1,844,713 $62.8 Million
Q2 2024 Aug 09, 2024	BUY	$18.86 - $23.55 $2.39 Million - $2.98 Million	126,486 Added 7.44%	1,826,792 $39.6 Million
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $1.75 Million - $2.43 Million	83,541 Added 5.17%	1,700,306 $37.7 Million
Q4 2023 Feb 13, 2024	BUY	$19.72 - $28.68 $1.45 Million - $2.11 Million	73,624 Added 4.77%	1,616,765 $44.5 Million
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $1.22 Million - $1.64 Million	54,734 Added 3.68%	1,543,141 $34.5 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $1.13 Million - $1.45 Million	53,889 Added 3.76%	1,488,407 $37.9 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $1.24 Million - $1.67 Million	60,026 Added 4.37%	1,434,518 $32 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $779,952 - $1.53 Million	50,944 Added 3.85%	1,374,492 $32.6 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $503,766 - $847,713	30,384 Added 2.35%	1,323,548 $22 Million
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $988,846 - $1.89 Million	64,003 Added 5.21%	1,293,164 $25.7 Million
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $245,442 - $475,559	-11,187 Reduced 0.9%	1,229,161 $33.9 Million
Q4 2021 Feb 11, 2022	BUY	$36.09 - $53.79 $1.41 Million - $2.1 Million	39,125 Added 3.26%	1,240,348 $51.1 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $418,641 - $622,556	11,753 Added 0.99%	1,201,223 $55.8 Million
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $2.31 Million - $3.97 Million	70,037 Added 6.26%	1,189,470 $47.6 Million
Q1 2021 May 12, 2021	BUY	$44.47 - $81.38 $9.78 Million - $17.9 Million	219,832 Added 24.44%	1,119,433 $60.2 Million
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $2.36 Million - $4.5 Million	72,664 Added 8.79%	899,601 $44 Million
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $2.39 Million - $3.19 Million	89,355 Added 12.11%	826,937 $26.9 Million
Q2 2020 Aug 13, 2020	BUY	$19.49 - $28.11 $793,204 - $1.14 Million	40,698 Added 5.84%	737,582 $19.1 Million
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $586,567 - $1.1 Million	36,365 Added 5.51%	696,884 $16.9 Million
Q4 2019 Feb 13, 2020	BUY	$20.78 - $29.99 $483,363 - $697,597	23,261 Added 3.65%	660,519 $18.4 Million
Q3 2019 Nov 12, 2019	BUY	$23.87 - $30.93 $1.5 Million - $1.95 Million	63,019 Added 10.97%	637,258 $15.3 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $2.82 Million - $3.64 Million	127,555 Added 28.56%	574,239 $16.4 Million
Q1 2019 May 14, 2019	BUY	$12.0 - $25.76 $666,564 - $1.43 Million	55,547 Added 14.2%	446,684 $11.2 Million
Q4 2018 Feb 13, 2019	BUY	$9.15 - $14.85 $121,338 - $196,925	13,261 Added 3.51%	391,137 $4.92 Million
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $1.79 Million - $2.37 Million	187,135 Added 98.11%	377,876 $3.61 Million
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $191,091 - $342,475	35,453 Added 22.83%	190,741 $1.78 Million
Q1 2018 May 15, 2018	BUY	$5.44 - $6.97 $9,797 - $12,552	1,801 Added 1.17%	155,288 $863,000
Q4 2017 Feb 13, 2018	SELL	$6.05 - $9.37 $17,762 - $27,510	-2,936 Reduced 1.88%	153,487 $1 Million
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $176,498 - $198,193	22,599 Added 16.89%	156,423 $1.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	133,824	133,824 $1.11 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.8B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Veracyte, Inc. Transaction History